June 19, 2026 DCVMN at the 3rd Global Private Sector Engagement Forum on the Importance of Workforce Development for a Resilient Health System DCVMN Advocacy developingcountries Workforce Training
June 10, 2026 DCVMN CEO and Members at the 3rd Vaccine World Forum DCVMN Advocacy developingcountries WeConnectToProtect
May 21, 2026 DCVMN Leadership Shapes Global Health Dialogue Through Strategic Engagements at WHA79 DCVMN Advocacy WeConnectToProtect
May 18, 2026 Indonesia and DCVMN co-organise official WHA79 side event “Advancing Local Production for Equitable Access, Resilient Health Systems, and Global Health Security” DCVMN achievements DCVMN Advocacy WeConnectToProtect
May 4, 2026 Serum Institute of India Entered Licence Agreement with the University of Oxford to Advance the Development of a Next-Generation Multi-Stage Malaria Vaccine Malaria Members' achievements Vaccines & immunization
April 24, 2026 DCVMN Awarded 2026 MahnHoon Award for Advancing Vaccine Equity CEO DCVMN achievements WeConnectToProtect
April 23, 2026 From Lecture Halls to Manufacturing Floors: DCVMN in South Korea DCVMN achievements DCVMN Advocacy Members
April 17, 2026 Another Succesful DCVMN Technology Transfer Training Delivered DCVMN achievements Technology Transfer Workforce Training
April 3, 2026 DCVMN at the World Vaccine Congress 2026: Advancing AI, Sustainability, and Global Vaccine Equity DCVMN Advocacy DCVMN Board Vaccines & immunization
February 23, 2026 DCVMN Launches the 7th Edition of its Technology Transfer Training DCVMN achievements Technology Transfer Workforce Training
February 17, 2026 Regulatory and PV Working Groups Constructing the Road Ahead DCVMN achievements DCVMN Working Groups WeConnectToProtect
